Shares of Impact Biomedical Inc. (NYSEAMERICAN:IBO – Free Report) are set to reverse split on the morning of Wednesday, September 23rd. The 1-12.62 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, September 22nd.
Impact Biomedical Price Performance
Shares of Impact Biomedical stock opened at $0.59 on Friday. The firm has a 50-day moving average of $0.46 and a 200-day moving average of $0.53. Impact Biomedical has a 52-week low of $0.37 and a 52-week high of $0.83.
Impact Biomedical (NYSEAMERICAN:IBO – Get Free Report) last released its quarterly earnings results on Friday, August 7th. The company reported ($0.01) EPS for the quarter. Impact Biomedical had a net margin of 2,254.28% and a return on equity of 8.81%. The business had revenue of $0.00 million during the quarter.
Impact Biomedical Company Profile
Impact Biomedical, Inc is a biotechnology company focused on developing technologies intended to address infectious diseases and other healthcare challenges. The company’s activities center on biomedical research, product development and the potential commercialization of medical and health-related solutions.
Impact Biomedical has pursued a portfolio of proprietary technologies, including antiviral and immune-support platforms designed to support the prevention or treatment of viral infections.
Recommended Stories
- Five stocks we like better than Impact Biomedical
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Impact Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Impact Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
